oxazoles has been researched along with d 609 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Day, BW; Lazo, JS; Pestell, KE; Vogt, A; Wipf, P | 1 |
1 other study(ies) available for oxazoles and d 609
Article | Year |
---|---|
The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activity.
Topics: Alkaline Phosphatase; Animals; Blotting, Western; Bridged-Ring Compounds; Cell Division; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Genes, ras; Inhibitory Concentration 50; Mitogen-Activated Protein Kinases; Models, Chemical; Models, Molecular; Norbornanes; Oxazoles; Phospholipase D; Phospholipids; Rats; Signal Transduction; Thiocarbamates; Thiones; Time Factors; Type C Phospholipases; Wound Healing | 2002 |